Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118388585A enables high-yield amide synthesis with low racemization. Offers supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel Ti-Si catalyst for DPC synthesis via transesterification. High stability, >60% conversion. Cost-effective pharma/polymer intermediate solution.
Patent CN103724294A reveals a novel route for Quetiapine intermediates, eliminating high-temperature distillation to ensure superior purity and supply chain stability.
This report analyzes patent CN104961715B for Dapagliflozin production offering reduced impurities and scalable manufacturing solutions for global pharmaceutical supply chains.
Novel preparation method for Gedatolisib intermediates using accessible raw materials. Reduces heavy metal residues and simplifies scale-up for reliable supply chain partners.
Patent CN118388585A reveals green visible light catalysis for amide synthesis. Reduces racemization and enhances supply chain reliability for pharmaceutical intermediates globally.
Novel photocatalytic route for SC 69124 ensures high purity and supply continuity. Reduces complexity in pharmaceutical intermediates manufacturing for global partners.
Advanced patent-based synthesis of 4-Methylsulfonyltoluene offers high purity and cost efficiency for pharmaceutical intermediate supply chains globally.
Patent CN102336710B reveals efficient synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel Fe-MOFs catalyst method for PCMX synthesis achieves high purity 99.7%. Enables cost reduction in disinfectant manufacturing. Reliable PCMX supplier for global supply chains.
Patent CN112358389A details a green LED-driven synthesis of Vitamin K3 intermediate, offering metal-free production and superior purity for reliable supply chains.
Patent CN109988161A details a telescoped synthesis for Empagliflozin, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN107163073A reveals copper-catalyzed silylation using water. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN104744437A details a simplified rabeprazole preparation method offering significant supply chain stability and cost reduction in API manufacturing for global partners.
Patent CN101863854A details a cost-effective synthesis of 2-(3-cyano-4-isobutoxy)phenyl-4-methyl-5-thiazolecarboxylic acid using bromination, offering high purity and scalability.
Novel Topiroxostat preparation using Potassium Ferrocyanide. High purity >99%, safe industrial scale-up, cost-effective API intermediate manufacturing.
Novel method for azithromycin impurity synthesis ensures high purity. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102465159B details a green microbial route for Eslicarbazepine. Enhance supply chain reliability and reduce manufacturing costs with this scalable biocatalytic technology.
Patent CN102465159B enables green microbial synthesis. Reduces cost and improves supply chain reliability for epilepsy drug intermediates significantly.